RxDoctor Payments Data

Kathryn Hawks, DO

Family Medicine · Athens, TNNPI 1336727270

Payments from drug & device makers

$1,170in general payments, 2019–2025

Across 58 payments — averaging $20.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$248
  • Pfizer$176
  • Heartflow, Inc.$132
  • AbbVie$105
  • Amgen$61
  • Exact Sciences$46
  • plus $401 from 14 others

What the payments were for

  • Food & beverage$1,170100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,170 in reported general payments places this provider in the 60th percentile of 2,087 family medicine providers in Tennessee.

See all family medicine providers in Tennessee

Medicare billing

Part B allowed, 2024
$35,855
Medicare patients
106
Services billed
944

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin22$28,081
MounjaroTirzepatide18$23,893
OzempicSemaglutide16$16,284
Albuterol Sulfate HfaAlbuterol Sulfate98$2,667
Omeprazole36$770
Atorvastatin Calcium74$684
Lisinopril130$624
Doxepin Hcl11$618
Chlorthalidone25$495
Hydroxyzine Hcl13$488
Fluticasone Propionate27$441
Levothyroxine Sodium63$440
Amitriptyline Hcl14$427
Pravastatin Sodium15$419
Pantoprazole Sodium36$409

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro$34$23,89318 claims
Novo NordiskOzempic$248$16,28416 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 2,087 family medicine providers in Tennessee.

Other family medicine in Athens

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →